More on TLX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.45 |
|
|||
| Open | $11.45 | ||||
| 52 Wk High | $2.18 | ||||
| 52 Wk Low | $0.30 | ||||
| Day High | $11.45 | ||||
| Day Low | $11.45 | ||||
| P/E | N/A | ||||
| EPS | $-3.32 | ||||
| Volume | 868 | ||||
- H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
- Form 6-K Telix Pharmaceuticals For: Jun 30
- Citi on Telix Pharmaceuticals Ltd (TLX): 'Opens 30-Day Upside Catalyst Watch'
- Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
- Telix to Host R&D Day in New York City on September 22, 2026
- Telix H1 2026 Results: Investor Webcast Notification
- H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
- Telix Pharmaceuticals Ltd (TLX:AU) (TLX) PT Raised to AUD24.40 at JPMorgan
- Telix publishes Phase 1 prostate cancer therapy study in Cancers journal
- TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
Entities mentioned with TLX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Earnings | View Related Stories »
- Show More...
